In addition, the analysis of ADGRD1 in NSCLC may bring hope for strengthening the prevention of NSCLC, improving the treatment of NSCLC patients, and enhancing the survival rate of patients. This evidence concerns the gene ADGRD1 and non-small cell lung carcinoma.